PRINCETON, N.J., Feb. 26, 2013 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on technology stocks, has issued updated outlooks for Avago Technologies (Nasdaq: AVGO), OmniVision Technologies (Nasdaq: OVTI), EZchip Semiconductor (Nasdaq: EZCH), Spreadtrum Communications (Nasdaq: SPRD) and Marvell Technology Group (Nasdaq: MRVL).
Editor Paul McWilliams spent a decades-long career as a senior executive in the technology industry and has earned a reputation for his skill in communicating complex technology trends to individual investors and professional analysts alike. His reports have won over readers with their ability to unravel the complexities of the industry and, more importantly, identify which companies are likely to be the winners and losers as technology trends change.
Each quarter, Next Inning publishes weekly earnings previews covering dozens of technology stocks, giving investors both long-term and short-term opinions to help shape their investment strategy.
Among the stocks where Next Inning was positive ahead of Q4 earnings so far were Cree (up 28% year to date), PMC Sierra (up 22% year to date) and QLogic (up 17% year to date); he was bearish on Cypress (down 9% year to date).
To get ahead of the Wall Street curve and receive Next Inning's in depth earnings previews for free, as well as McWilliams' year-end State or Tech report, you are invited to take a free, 21-day, no obligation trial with Next Inning. For full details on this offer, please visit the following link:
Topics discussed in the latest reports include:
-- Avago: Is there more to the Avago story than its positioning as a supplier to Apple? What two strategic high-growth sectors can investors cover by owning shares in Avago? Is Avago's positioning in the RF semiconductor market threatened by new product developments at Qualcomm? Should investors hold onto shares of Avago through the company's earnings report today, or is now a good time to hedge positions?
-- Omnivision: While acknowledging the demand for image sensors will continue to grow, McWilliams has long maintained that OmniVision is not a stock to hold for the long term, but a great stock for swing trading. After calling several profitable swing trades in the past, does McWilliams think investors should buy OmniVision ahead of its earnings call this week or should they pass on the opportunity this quarter?
-- EZchip: It's not unusual to see EZchip trade with high volatility, but it's been nearly 30 months since we've seen it dip into the mid-$20s. What drove the selloff following EZchip's quarterly earnings call? Is there evidence that the EZchip business model is likely to be derailed, or is the selloff an overdone emotional reaction? With prospects of a 35% compounded annual growth rate (CAGR) for the next four years and balance sheet worth over $5 per share, what does McWilliams view as a realistic price target range for EZchip? Trial subscribers will get full access to McWilliams' in-depth post earnings report covering EZchip.
-- Spreadtrum: What is behind the recent volatility in shares of Spreadtrum? Is Spreadtrum likely to emerge as viable competitor to Qualcomm and MediaTek in China?
-- Marvell: Marvell reported its Q4 2013 earnings in line with what McWilliams predicted in his earnings preview, and shares have moved higher even as other tech stock prices have fallen. What is McWilliams' forecast for the balance of 2013 and what does he view as a realistic price objective?
Founded in September 2002, Next Inning's model portfolio has returned 233% since its inception versus 65% for the S&P 500.
About Next Inning:
Next Inning is a subscription-based investment newsletter that provides regular coverage on more than 150 technology and semiconductor stocks. Subscribers receive intra-day analysis, commentary and recommendations, as well as access to monthly semiconductor sales analysis, regular Special Reports, and the Next Inning model portfolio. Editor Paul McWilliams is a 30+ year semiconductor industry veteran.
NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcia Martin, Next Inning Technology Research, +1-888-278-5515
SOURCE Indie Research Advisors, LLC